Clinical trial
Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients
NCT00005009 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00005009 |
|---|---|
| Title | Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients |
| Official title | Evaluation of the Safety and Immunogenicity of Varivax® (Live-Attenuated Varicella-Zoster Virus Vaccine) in Pediatric Renal Transplant Recipients |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Merck Sharp & Dohme LLC Industry Cooperative Clinical Trials in Pediatric Transplantation North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) NIAID Vaccine and Treatment… |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Transplant Recipients |
| Intervention type | Biological |
| Interventions | Varivax® |
| Enrollment | 7 |
| Start date | Feb 1, 1998 |
| Primary completion | Jun 16, 2001 |
| Completion | Jun 16, 2001 |
| First posted | Aug 31, 2001 |
| Last update posted | Feb 16, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: